Literature DB >> 1928954

Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barré syndrome.

J C Chevrolet1, P Deléamont.   

Abstract

In Guillain-Barré syndrome (GBS), respiratory failure is a life-threatening complication, and its occurrence may be difficult to predict. We studied prospectively 10 patients with GBS by serial measurements of pulmonary function and arterial blood gases from the the time they were admitted to hospital. Five patients developed respiratory failure and had to be intubated, whereas the other five developed no ventilatory impairment. VC measurements were very useful in predicting respiratory failure several days before intubation. In patients who were eventually intubated, VC decreased during the 48 h preceding the occurrence of respiratory failure and intubation, which was required when VC was 15.2 +/- 3.7 ml/kg body weight (BW). In nonintubated patients, VC was stable and greater than 40 ml/kg BW. In addition, VC measurements allowed us to determine the beginning of the weaning procedure (no weaning trial could be performed successfully when VC was less than 7 ml/kg BW), to rationally follow its course, and to choose the time for extubation, i.e., when VC was greater than 15 ml/kg BW.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928954     DOI: 10.1164/ajrccm/144.4.814

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  EMG and duration of ventilatory support in children with Guillain-Barre syndrome.

Authors:  Fernando Ortiz-Corredor; Jorge Díaz-Ruiz; Alvaro Izquierdo-Bello
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

Review 2.  Assessment of respiratory muscle function and strength.

Authors:  N Syabbalo
Journal:  Postgrad Med J       Date:  1998-04       Impact factor: 2.401

3.  Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome.

Authors:  David Orlikowski; Tarek Sharshar; Raphael Porcher; Djillali Annane; Jean Claude Raphael; Bernard Clair
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

4.  Respiratory Muscle Assessment in Acute Guillain-Barré Syndrome.

Authors:  S Walterspacher; A Kirchberger; J Lambeck; D J Walker; A Schwörer; W D Niesen; W Windisch; F Hamzei; H J Kabitz
Journal:  Lung       Date:  2016-08-09       Impact factor: 2.584

Review 5.  Respiratory dysfunction in Guillain-Barré Syndrome.

Authors:  David Orlikowski; Hélène Prigent; Tarek Sharshar; Frédéric Lofaso; Jean Claude Raphael
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Vital capacity versus maximal inspiratory pressure in patients with Guillain-Barré syndrome and myasthenia gravis.

Authors:  Hélène Prigent; David Orlikowski; Nadège Letilly; Line Falaize; Djilali Annane; Tarek Sharshar; Frédéric Lofaso
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 7.  Measurement of respiratory muscle strength.

Authors:  M I Polkey; M Green; J Moxham
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

Review 8.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

9.  The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

Authors:  P Rieder; M Louis; P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

Review 10.  Advances in the management of Guillain-Barré syndrome.

Authors:  Deborah M Green
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.